Attention deficit hyperactivity disorder (ADHD) affects hundreds of millions worldwide, yet effective non-medication treatment options remain limited. A Sydney-based startup called Neurode may have developed a novel solution – a lightweight headband capable of both tracking and treating ADHD symptoms through minimally invasive brain stimulation.
Co-founder Nathalie Gouailhardou, who has lived with ADHD since childhood, wanted to create an alternative for patients like herself who found stimulant medications ineffective or undesirable due to side effects. Her background in neuroscience led to the idea of miniaturizing expensive brain imaging technology into an accessible at-home device.
Working with co-founder Damian Sofrevski, Gouailhardou helped design a headband that uses light electrical pulses targeted at the prefrontal cortex. Early users report this stimulation can balance brain activity and enhance focus over time. The device also monitors changes through a non-invasive brain scanning method.
Backed by $3.5 million in funding, Neurode is currently testing the headband through a private beta program. If approved, it could offer patients a drug-free treatment requiring just 20 minutes daily. While medication remains first-line, Neurode hopes to establish the first FDA-cleared device for ADHD symptom management.
Investors see potential for innovation in a space dominated by older pharmaceutical options. If clinical trials prove successful, Neurode may transform ADHD treatment through accessible, personalized care delivered at home. Gouailhardou and her team aim to empower patients worldwide balancing brain health through novel technology.
